EDITORIAL
Using biomaterials research to address the challenges raised by the COVID-19 pandemic
Qian Wang
2021, 2(1): 1-2. doi:10.3877/cma.j.issn.2096-112X.2021.01.001
VIEWPOINT
Development of personal protective equipment for the COVID-19 pandemic in Thailand and technical aspects of testing gown materialsVisarut Buranasudja, Anongnat Somwangthanaroj, Suched Likitlersuang, Tirawat Boonyatee, Chartchalerm Isarankura-Na-Ayudhya, Jittima Amie Luckanagul
2021, 2(1): 3-9. doi:10.3877/cma.j.issn.2096-112X.2021.01.002
REVIEW
Physicochemical properties of respiratory droplets and their role in COVID-19 pandemics: a critical reviewTing Ge, Shengfeng Cheng
2021, 2(1): 10-18. doi:10.3877/cma.j.issn.2096-112X.2021.01.003
|
The coronavirus causing COVID-19 relies on respiratory droplets as the main carrier for its transmission. Understanding the physical characteristics of respiratory droplets and their fate after being released into air plays a crucial role in helping develop mitigating measures and policies to fight the ongoing pandemic that plagues the world. |
Yiqing Wang, Xiangyu Chu, Bing Wang
2021, 2(1): 19-29. doi:10.3877/cma.j.issn.2096-112X.2021.01.004
|
A schematic diagram illustrating recombinant adeno-associated viral (rAAV)-based gene therapy combined with a tissue-engineered biomaterial scaffold. rAAV-modified stem cells and gene-activated biomaterials can be applied to bone, vertebral disc, cartilage or muscle to treat multiple musculoskeletal disorders. |
Isak Jatoi, Jingyu Fan
2021, 2(1): 30-42. doi:10.3877/cma.j.issn.2096-112X.2021.01.005
|
Four vaccine types derived from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus are depicted, namely, DNA-based, viral vector, RNA-based, and protein subunit vaccines. Vaccine uptake, processing, and presentation by an antigen-presenting cell (APC) are also illustrated for these four vaccine mechanisms. |
RESEARCH ARTICLE
Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosisKaewta Rattanapisit, Gorawit Yusakul, Balamurugan Shanmugaraj, Kittinop Kittirotruji, Phassorn Suwatsrisakul, Eakachai Prompetchara, Suthira Taychakhoonavud, Waranyoo Phoolcharoen
2021, 2(1): 43-49. doi:10.3877/cma.j.issn.2096-112X.2021.01.006
|
Plant-produced recombinant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain (RBD) was used to develop a lateral flow immunoassay strip (LFIA) for detecting IgM/IgG antibodies. |
Dahae Seong, Monchupa Kingsak, Yuan Lin, Qian Wang, Shamia Hoque
2021, 2(1): 50-59. doi:10.3877/cma.j.issn.2096-112X.2021.01.007
To limit transmission due to infectious droplets we must understand, “What factors control the transport, deposition, adhesion, and persistence of pathogens indoors?” The pandemic has reinforced the necessity of establishing baseline information on how viruses under indoor environmental conditions optimize survivability and transmission. Virus-surface interactions investigations using vaccinia virus sheds light on part of the picture.